Study Details

Population Genetics Analysis Program: Immunity to Vaccines/Infections Genetic Risk for Smallpox Vaccine Relate to Myocarditis

Robert L. Davis, Principal Investigator


The study aim is to determine the rate of abnormalities in electrocardiogram and/or troponin elevation and/or other clinical indicators suggestive of symptomatic or asymtomatic myopericarditis within 30 days following influenza or smallpox vaccination in a group of adults eligable for immunization.
Funding source: National Institutes for Health through a subcontract with the University of Washington

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente